Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases
2016 · Nature Medicine · 423 citations
https://doi.org/10.1038/nm.4197
P
Patrycja Gazińska
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
252
Papers
4.5K
Citations
30
h-index
43
i10-index
Patrycja Gazińska is an academic researcher from Wrocław University of Science and Technology. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Cancer Genomics and Diagnostics & Lung Cancer Treatments and Mutations. The author has an h-index of 30, co-authored 215 publications.
ORCID: 0000-0001-5031-1913Papers by this author
worksPhase II Randomized Preoperative Window-of-Opportunity Study of the PI3K Inhibitor Pictilisib Plus Anastrozole Compared With Anastrozole Alone in Patients With Estrogen Receptor–Positive Breast Cancer
2016 · Journal of Clinical Oncology · 95 citations
https://doi.org/10.1200/jco.2015.63.9179
Integrated genomic analysis of triple-negative breast cancers reveals novel microRNAs associated with clinical and molecular phenotypes and sheds light on the pathways they control
2013 · BMC Genomics · 87 citations
https://doi.org/10.1186/1471-2164-14-643
Ubiquitylation of MLKL at lysine 219 positively regulates necroptosis-induced tissue injury and pathogen clearance
2021 · Nature Communications · 74 citations
https://doi.org/10.1038/s41467-021-23474-5
Integrated genomics and functional validation identifies malignant cell specific dependencies in triple negative breast cancer
2018 · Nature Communications · 56 citations
https://doi.org/10.1038/s41467-018-03283-z
SF3B1 hotspot mutations confer sensitivity to PARP inhibition by eliciting a defective replication stress response
2023 · Nature Genetics · 41 citations
https://doi.org/10.1038/s41588-023-01460-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat